Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Gilead Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Gilead Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Gilead Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Gilead Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Gilead Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Gilead Sciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Kite Pharma Enters into Agreement with Vitruvian Networks 11
Debt Offering 12
Gilead Sciences Raises USD750 Million in Public Offering of Notes Due 2018 12
Gilead Sciences Raises USD1 Billion in Public Offering of 1.85% Notes Due 2019 14
Gilead Sciences Raises USD750 Million in Public Offering of Notes Due 2019 16
Gilead Sciences Raises USD500 Million in Public Offering of Notes Due 2019 18
Gilead Sciences Raises USD1.25 Billion in Public Offering of 2.95% Notes Due 2027 20
Gilead Sciences Raises USD0.5 Billion in Public Offering of 1.95% Notes Due 2022 22
Gilead Sciences Raises USD1.75 Billion in Public Offering of 4.15% Notes Due 2047 24
Gilead Sciences Raises USD0.75 Billion in Public Offering of 4% Notes Due 2036 26
Gilead Sciences Raises USD0.75 Billion in Public Offering of 2.5% Notes Due 2023 28
Gilead Sciences Raises USD2.25 Billion in Public Offering of 4.75% Notes Due 2046 30
Gilead Sciences Raises USD1 Billion in Public Offering of 1.85% Notes Due 2018 32
Gilead Sciences Raises USD1 Billion in Public Offering of 3.25% Notes Due 2022 34
Gilead Sciences Raises USD2 Billion in Public Offering of 2.55% Notes Due 2020 36
Gilead Sciences Raises USD2.75 Billion in Public Offering of 3.65% Notes Due 2026 38
Gilead Sciences Raises USD1 Billion in Public Offering of 4.6% Notes Due 2035 40
Gilead Sciences Inc – Key Competitors 42
Gilead Sciences Inc – Key Employees 43
Gilead Sciences Inc – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Joint Venture 49
Recent Developments 50
Strategy And Business Planning 50
May 15, 2018: Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline 50
Financial Announcements 51
Jul 25, 2018: Gilead Sciences Announces Second Quarter 2018 Financial Results 51
May 01, 2018: Gilead Sciences Announces First Quarter 2018 Financial Results 54
Feb 06, 2018: Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results 56
Oct 26, 2017: Gilead Sciences Announces Third Quarter 2017 Financial Results 59
Jul 26, 2017: Gilead Sciences Announces Second Quarter 2017 Financial Results 61
May 02, 2017: Gilead Sciences Announces First Quarter 2017 Financial Results 63
Feb 07, 2017: Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results 65
Corporate Communications 67
Aug 28, 2018: Gilead Sciences names Laura Hamill as executive vice president, worldwide commercial operations 67
Aug 14, 2018: Gilead Sciences Announces Executive Promotions 68
Jul 25, 2018: Gilead Sciences announces CEO John F. Milligan to step down 69
Jun 11, 2018: Gilead Sciences’ Chief Scientific Officer John McHutchison Appointed Officer of the Order of Australia 70
Jun 04, 2018: Gilead Sciences Announces Leadership Changes in Corporate Development and Strategy 71
May 15, 2018: Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline 72
May 09, 2018: Harish Manwani Joins Gilead Sciences’ Board of Directors 73
Mar 12, 2018: Gilead Sciences Announces Senior Management Changes 74
Feb 22, 2018: Gilead Sciences Announces Senior Management Change 75
Feb 01, 2018: Gilead Sciences Appoints Jacqueline K. Barton As Board of Directors 76
Dec 14, 2017: Gilead Sciences Announces That John C. Martin, PhD Will Transition From Executive Chairman to Chairman of the Board of Directors 77
Oct 17, 2017: Gilead Sciences Announces Promotion of Alessandro Riva to Executive Vice President, Oncology Therapeutics 78
Sep 27, 2017: Kevin Young CBE, Gilead’s Chief Operating Officer, to Retire 79
Jan 03, 2017: Alessandro Riva, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutic Area Head 80
Appendix 81
Methodology 81
About GlobalData 81
Contact Us 81
Disclaimer 81
Gilead Sciences Inc, Medical Equipment, Key Facts, 2017 2
Gilead Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Gilead Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Gilead Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Gilead Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Gilead Sciences Inc, Deals By Market, 2012 to YTD 2018 9
Gilead Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Kite Pharma Enters into Agreement with Vitruvian Networks 11
Gilead Sciences Raises USD750 Million in Public Offering of Notes Due 2018 12
Gilead Sciences Raises USD1 Billion in Public Offering of 1.85% Notes Due 2019 14
Gilead Sciences Raises USD750 Million in Public Offering of Notes Due 2019 16
Gilead Sciences Raises USD500 Million in Public Offering of Notes Due 2019 18
Gilead Sciences Raises USD1.25 Billion in Public Offering of 2.95% Notes Due 2027 20
Gilead Sciences Raises USD0.5 Billion in Public Offering of 1.95% Notes Due 2022 22
Gilead Sciences Raises USD1.75 Billion in Public Offering of 4.15% Notes Due 2047 24
Gilead Sciences Raises USD0.75 Billion in Public Offering of 4% Notes Due 2036 26
Gilead Sciences Raises USD0.75 Billion in Public Offering of 2.5% Notes Due 2023 28
Gilead Sciences Raises USD2.25 Billion in Public Offering of 4.75% Notes Due 2046 30
Gilead Sciences Raises USD1 Billion in Public Offering of 1.85% Notes Due 2018 32
Gilead Sciences Raises USD1 Billion in Public Offering of 3.25% Notes Due 2022 34
Gilead Sciences Raises USD2 Billion in Public Offering of 2.55% Notes Due 2020 36
Gilead Sciences Raises USD2.75 Billion in Public Offering of 3.65% Notes Due 2026 38
Gilead Sciences Raises USD1 Billion in Public Offering of 4.6% Notes Due 2035 40
Gilead Sciences Inc, Key Competitors 42
Gilead Sciences Inc, Key Employees 43
Gilead Sciences Inc, Other Locations 45
Gilead Sciences Inc, Subsidiaries 45
Gilead Sciences Inc, Joint Venture 49
List of Figures
Gilead Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Gilead Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Gilead Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Gilead Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Gilead Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Gilead Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Gilead Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Gilead Sciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9